3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
27
Multiple Myeloma
20
Recurrence
19
Lymphoma, Non-Hodgkin
15
Lymphoma, B-Cell
14
Lymphoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Ovarian Neoplasms
12
Hematologic Neoplasms
12
Melanoma
11
Pancreatic Neoplasms
10
Myeloproliferative Disorders
10
Burkitt Lymphoma
10
Leukemia
9
Hodgkin Disease
9
Stomach Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia, Biphenotypic, Acute
8
Neoplasms
7
Leukemia, Myelomonocytic, Chronic
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Osteosarcoma
6
Neuroblastoma
6
Neoplasm Metastasis
6
Lymphoma, Mantle-Cell
6
Lymphoma, Follicular
6
Interventions
decitabine and cedazuridine drug combination
1
Pluvicto
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cytopenia
×
fludarabine
×
90 days
×
Clear all
No trials found.